Clinical Safety

Seoul Court to Rule on Genencell Founder's COVID Drug Fraud
Research & Development Seoul Court to Rule on Genencell Founder's COVID Drug Fraud

The upcoming appellate verdict for Kang will address specific charges of submitting fraudulent animal testing data to the Ministry of Food and Drug Safety for a potential antiviral drug. This legal proceeding serves as a critical juncture for the South Korean pharmaceutical industry, highlighting

Telehealth Growth Sparks Privacy and Deception Concerns
Management & Regulatory Telehealth Growth Sparks Privacy and Deception Concerns

While the COVID-19 pandemic accelerated the shift toward virtual care, the rapid growth of telehealth platforms has outpaced the federal regulations intended to protect sensitive patient data. For millions of Americans, the appeal of services like Hims & Hers, BetterHelp, and GoodRx lies in the

Camel Meniscus Tissue Shows Promise for Human Knee Repair
Management & Regulatory Camel Meniscus Tissue Shows Promise for Human Knee Repair

Researchers at Birjand University of Medical Sciences are targeting the unique mechanical requirements of the knee by leveraging the dense native collagen found in camels. This specific focus on camel-derived tissue addresses one of the most persistent challenges in orthopedic medicine: the repair

Analysis of BPC-157 Research and UK Regulatory Standards
Research & Development Analysis of BPC-157 Research and UK Regulatory Standards

Market availability of BPC-157 does not imply clinical safety, as materials intended for laboratory analysis are produced under different standards than those for human consumption. This synthetic pentadecapeptide, consisting of a sequence of fifteen amino acids, has become a prominent subject of

How Can Australia Secure the Future of Hospital Pharmacy?
Management & Regulatory How Can Australia Secure the Future of Hospital Pharmacy?

Meaningful empowerment for clinical pharmacists requires more than rhetoric; it demands a systemic overhaul of workforce models and safe staffing levels. In the current landscape, the Australian hospital sector is facing a critical juncture where the complexity of medication management has outpaced

FLOURISH Study Validates Osimertinib for Real-World Lung Cancer
Research & Development FLOURISH Study Validates Osimertinib for Real-World Lung Cancer

Baseline next-generation sequencing reveals that over 76 percent of lung cancer patients harbor additional genomic alterations that can shorten treatment durability. This statistic underscores the persistent challenge of managing advanced malignancies outside the sterile confines of traditional

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later